InvestorsHub Logo
Followers 21
Posts 475
Boards Moderated 0
Alias Born 01/22/2013

Re: ShinSekai post# 11176

Monday, 11/10/2014 10:50:39 AM

Monday, November 10, 2014 10:50:39 AM

Post# of 27557
How is this not a greenlight?-

November 10, 2014: 08:31 AM ET

iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™ platform for production by Caliber of antibodies that target the Ebola virus.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IBIO News